RATIONALE: Mutations in the cardiac type 2 ryanodine receptor (RyR2) have been linked to catecholaminergic polymorphic ventricular tachycardia (CPVT). CPVT-associated RyR2 mutations cause fatal ventricular arrhythmias in young individuals during β-adrenergic stimulation. OBJECTIVE: This study sought to determine the effects of a novel RyR2-G230C mutation and whether this mutation and RyR2-P2328S alter the sensitivity of the channel to luminal calcium (Ca(2+)). METHODS AND RESULTS: Functional characterizations of recombinant human RyR2-G230C channels were performed under conditions mimicking stress. Human RyR2 mutant channels were generated by site-directed mutagenesis and heterologously expressed in HEK293 cells together with calstabin2. RyR2 channels were measured to examine the regulation of the channels by cytosolic versus luminal sarcoplasmic reticulum Ca(2+). A 50-year-old white man with repeated syncopal episodes after exercise had a cardiac arrest and harbored the mutation RyR2-G230C. cAMP-dependent protein kinase-phosphorylated RyR2-G230C channels exhibited a significantly higher open probability at diastolic Ca(2+) concentrations, associated with a depletion of calstabin2. The luminal Ca(2+) sensitivities of RyR2-G230C and RyR2-P2328S channels were WT-like. CONCLUSIONS: The RyR2-G230C mutant exhibits similar biophysical defects compared with previously characterized CPVT mutations: decreased binding of the stabilizing subunit calstabin2 and a leftward shift in the Ca(2+) dependence for activation under conditions that simulate exercise, consistent with a "leaky" channel. Both RyR2-G230C and RyR2-P2328S channels exhibit normal luminal Ca(2+) activation. Thus, diastolic sarcoplasmic reticulum Ca(2+) leak caused by reduced calstabin2 binding and a leftward shift in the Ca(2+) dependence for activation by diastolic levels of cytosolic Ca(2+) is a common mechanism underlying CPVT.
RATIONALE: Mutations in the cardiac type 2 ryanodine receptor (RyR2) have been linked to catecholaminergic polymorphic ventricular tachycardia (CPVT). CPVT-associated RyR2 mutations cause fatal ventricular arrhythmias in young individuals during β-adrenergic stimulation. OBJECTIVE: This study sought to determine the effects of a novel RyR2-G230C mutation and whether this mutation and RyR2-P2328S alter the sensitivity of the channel to luminal calcium (Ca(2+)). METHODS AND RESULTS: Functional characterizations of recombinant humanRyR2-G230C channels were performed under conditions mimicking stress. HumanRyR2 mutant channels were generated by site-directed mutagenesis and heterologously expressed in HEK293 cells together with calstabin2. RyR2 channels were measured to examine the regulation of the channels by cytosolic versus luminal sarcoplasmic reticulum Ca(2+). A 50-year-old white man with repeated syncopal episodes after exercise had a cardiac arrest and harbored the mutation RyR2-G230C. cAMP-dependent protein kinase-phosphorylated RyR2-G230C channels exhibited a significantly higher open probability at diastolic Ca(2+) concentrations, associated with a depletion of calstabin2. The luminal Ca(2+) sensitivities of RyR2-G230C and RyR2-P2328S channels were WT-like. CONCLUSIONS: The RyR2-G230C mutant exhibits similar biophysical defects compared with previously characterized CPVT mutations: decreased binding of the stabilizing subunit calstabin2 and a leftward shift in the Ca(2+) dependence for activation under conditions that simulate exercise, consistent with a "leaky" channel. Both RyR2-G230C and RyR2-P2328S channels exhibit normal luminal Ca(2+) activation. Thus, diastolic sarcoplasmic reticulumCa(2+) leak caused by reduced calstabin2 binding and a leftward shift in the Ca(2+) dependence for activation by diastolic levels of cytosolic Ca(2+) is a common mechanism underlying CPVT.
Authors: Dawei Jiang; Peter P Jones; Darryl R Davis; Robert Gow; Martin S Green; David H Birnie; S R Wayne Chen; Michael H Gollob Journal: Channels (Austin) Date: 2010-07-14 Impact factor: 2.581
Authors: Christopher H George; Hala Jundi; N Lowri Thomas; Debra L Fry; F Anthony Lai Journal: J Mol Cell Cardiol Date: 2006-11-01 Impact factor: 5.000
Authors: Simon Sedej; Frank R Heinzel; Stefanie Walther; Nataliya Dybkova; Paulina Wakula; Jan Groborz; Phillip Gronau; Lars S Maier; Marc A Vos; F Anthony Lai; Carlo Napolitano; Silvia G Priori; Jens Kockskämper; Burkert Pieske Journal: Cardiovasc Res Date: 2010-01-15 Impact factor: 10.787
Authors: María Fernández-Velasco; Angélica Rueda; Nicoletta Rizzi; Jean-Pierre Benitah; Barbara Colombi; Carlo Napolitano; Silvia G Priori; Sylvain Richard; Ana María Gómez Journal: Circ Res Date: 2008-12-18 Impact factor: 17.367
Authors: C A Goddard; N S Ghais; Y Zhang; A J Williams; W H Colledge; A A Grace; C L-H Huang Journal: Acta Physiol (Oxf) Date: 2008-06-28 Impact factor: 6.311
Authors: Xiangsheng Yang; Tiannan Wang; Xi Lin; Xiaojing Yue; Qiongling Wang; Guoliang Wang; Qin Fu; Xun Ai; David Y Chiang; Christina Y Miyake; Xander H T Wehrens; Jiang Chang Journal: Circ Res Date: 2014-10-27 Impact factor: 17.367
Authors: M K Larsen; K E Berge; T P Leren; P H Nissen; J Hansen; I B Kristensen; J Banner; H K Jensen Journal: Int J Legal Med Date: 2012-01-06 Impact factor: 2.686
Authors: Jim W Cheung; Albano C Meli; Wenjun Xie; Suneet Mittal; Steven Reiken; Anetta Wronska; Linna Xu; Jonathan S Steinberg; Steven M Markowitz; Sei Iwai; Alain Lacampagne; Bruce B Lerman; Andrew R Marks Journal: Int J Cardiol Date: 2014-11-25 Impact factor: 4.164